Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Kidney Diseases · 2022 · 8 (1) · 57-71
DOI: 10.1159/000517723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 03.08.2021. Verfasst von Lu Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Ferroptosis, an iron-dependent form of regulated necrosis mediated by lipid peroxidation, predominantly polyunsaturated fatty acids, is involved in postischemic and toxic kidney injury. However, the role and mechanisms for tubular epithelial cell (TEC) ferroptosis in kidney fibrosis remain largely unknown.
Objectives
The aim of the study was to decipher the role and mechanisms for TEC ferroptosis in kidney fibrosis.
Methods
Mouse models with unilateral ureter obstruction (UUO) or ischemia/reperfusion injury (IRI) were generated.
Results
We found that TEC ferroptosis exhibited as reduced glutathione peroxidase 4 (GPX4) expression and increased 4-hydroxynonenal abundance was appeared in kidneys from chronic kidney disease (CKD) patients and mouse models with UUO or IRI. Inhibition of ferroptosis could largely mitigate kidney injury, interstitial fibrosis, and inflammatory cell accumulation in mice after UUO or IRI. Additionally, treatment of TECs with (1S,3R)-RSL-3, an inhibitor of GPX4, could enhance cell ferroptosis and recruit macrophages. Furthermore, inhibiting TEC ferroptosis reduced monocyte chemotactic protein 1 (MCP-1) secretion and macrophage chemotaxis.
Conclusions
This study uncovers that TEC ferroptosis may promote interstitial fibrosis and inflammation, and targeting ferroptosis may shine a light on protecting against kidney fibrosis in patients with CKDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
- Department of Clinical Genetics, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Zitieren
APA
Zhou, L., Xue, X., Hou, Q., & Dai, C. (2022). Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis. Kidney Diseases, 8(1), 57-71. https://doi.org/10.1159/000517723
Vancouver
Zhou L, Xue X, Hou Q, Dai C. Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis. Kidney Diseases. 2022;8(1):57-71. doi:10.1159/000517723
BibTeX
@article{Zhou2022,
author = {Zhou, Lu and Xue, Xian and Hou, Qing and Dai, Chunsun},
title = {Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis},
journal = {Kidney Diseases},
year = {2022},
volume = {8},
number = {1},
pages = {57--71},
doi = {10.1159/000517723}
}
EUVIMED